NTRANatera

Each row is one issuer’s token for Natera, with the chains it is deployed on. A bold chain is one where these wallets hold a balance. Tokens are not shares: no issuer in the registry publishes a shares-per-token ratio, so a balance is counted one per share and marked where that assumption is doing work.

Tokenized versions of Natera, the issuer behind each, the chains it is deployed on, and what these wallets hold of it.

Token	Issuer	Chains	You hold
rNTRA	Reality	ARB	—
NTRAx	xStocks	ETHBNBARBSOLTONMNTHYPEINKXLYROP

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

Type

Common stock

Sector

Healthcare › Life Sciences Tools & Services

Exchange

Nasdaq

Listed since

Jul 2, 2015

Shares outstanding

144.14M

Employees

6,140

As the market data provider names it. Where that differs from the issuers’ name for the security, both are shown so the difference is visible.